Neurology & Brain Health From blood tests to precision neurotherapy
For leaders moving brain health from late diagnosis and blunt categories to earlier detection, biomarker-guided treatment, and scalable precision neurology.
Confirmed neurology leaders
At PMWC 2027.
Alzheimer’s biomarkers, tau/amyloid/NfL, and earlier diagnosis tied to treatment readiness.
From biomarker to bedside across Alzheimer’s, Parkinson’s, ALS, FTD, stroke, and epilepsy.
Brain circuits, 40Hz gamma stimulation, digital biomarkers, and imaging-driven phenotyping.
Why: Track Focus
Neurology is finally getting measurable, actionable tools. The hard part now is using them without turning care delivery into a maze.
- Earlier diagnosis blood biomarkers, CSF, PET, imaging, and digital signals that identify disease before the window closes.
- Treatment selection matching patients to anti-amyloid therapies, trials, devices, and next-generation neurotherapeutics.
- Scale beyond academic centers lab workflows, payer logic, physician adoption, and patient access.
Who: Attends
Program themes
Are we finally diagnosing Alzheimer’s early enough for therapy, trial enrollment, and care planning?
How precision diagnostics enter routine neurology workflows across subspecialties.
Parkinson’s, ALS, FTD, and cross-disease biomarker strategies that keep the track broader than AD.
Precision phenotyping in stroke, epilepsy, and neurodegeneration, with clinical usefulness as the bar.
Coverage, access, clinician adoption, lab capacity, and the practical fixes precision neurology needs.
Gamma stimulation, brain circuits, and device-enabled approaches to the future of neurotherapy.
Confirmed institutions represented
Key challenges we help you solve
Which assays, which patients, which confirmatory tests, and how results actually change care.
Connecting diagnosis to anti-amyloid therapy, safety monitoring, trial options, and patient preference.
Building biomarker and clinical-development playbooks for Parkinson’s, ALS, FTD, stroke, and epilepsy.
Moving from “interesting signal” to validated phenotype, decision support, and measurable outcome.
Reimbursement, lab infrastructure, referral pathways, equity, and community adoption.
Making the model work outside elite centers, because pilots don’t help patients if they stay trapped in PowerPoint.
Bring precision neurology into real care
Register for the science, sponsor for the meetings, and skip the fog machine.
PMWC is indeed 'The Davos of Biotech'
Brook Byers, Founding Partner, Kleiner Perkins, Pioneer in Life Sciences & Healthcare Investing
Congratulations on another super successful conference. What you have created is a unique format that allows for easy face to face meetings, even with legends in the hall. I love it.
Brook Byers, Founding Partner, Kleiner Perkins, Pioneer in Life Sciences & Healthcare Investing
There is no other event with such a lineup of leaders in their field. My annual MUST event since 2013!
Thomas Wilckens, MD, VP Precision Medicine & Precision Health, ECTT
You truly have an all-star, world-class crew lined up!
Alexis Hall, PhD, Professor
I am thrilled to hear about the impressive 2026 lineup of speakers and the engaging topics planned for the conference.
Amanda Acerbi, PharmD, Precision Medicine Global Director, Janssen (J&J)
PMWC is a landmark event, a real tour de force in precision medicine!
Mehme Hachem, PhD, Sr. Bioinformatician, IO / ML, Université de Montréal
The conference is excellent, and the 2026 speaker lineup is truly stellar — it seems to get stronger every year.
Mike Zack, MD, PhD, MPH, CEO & Co‑Founder, PGxAI
I just registered, fantastic lineup! Can't wait for this!
Thierry Giffon, PhD, Immunologist, Translational Scientific Leader
Congrats. This is an amazing rock star lineup.
Amanda Cashin, PhD, Bio Company Builder & Investor, Wing VC
The PMWC program and speaker lineup is one of the most impactful and thoughtfully curated conferences in healthcare today.
Tanmay Khilnani, Founder & Chief, Dept. of Medicine, University of Washington
I’ve spoken and had exhibitions in the past at PMWC — one of my favorite conferences of the year — and this 2026 year is extra impressive.
Tod Klingler, PhD, Co‑Founder & CEO, GeneLeap
Tal has done an amazing job developing the PMWC into the #1 premier precision medicine conference.
Trish Brown, SVP, Payer Relations and Reimbursement, GeneDx
Incredible line up! Great event you are putting on
Christina Zigliotto, Head of Generative AI & Machine Learning, Amazon AWS
What an impressive lineup.
I‑Chen Fong, PharmD, Ambulatory Care Pharmacist, Kaiser Permanente
Congratulations on the amazing speaker lineup this year. Wow!
Snehit Prabhu, PhD, Chief Data Scientist, Cancer Cell Therapy, Stanford Cancer Institute
PMWC 2025 was excellent, and the lineup sounds truly impressive!
Liat Dassa, PhD, Director of Program Planning, Biology & Computational Models, CytoReason
The line up has come together beautifully and quite impressively. Many people have mentioned how much they are looking forward to it.
Andrea Vuturo, Partner, Vuturo Group




